Release 4B Ballot #1

This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0310.xml

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Device, Encounter, Patient, Practitioner, RelatedPerson

Raw XML (canonical form + also see XML Format Specification)

Jump past Narrative

Oral Chemotherapy - Myleran (id = "medadmin0310")

<?xml version="1.0" encoding="UTF-8"?>

<MedicationAdministration xmlns="http://hl7.org/fhir"> 
  <id value="medadmin0310"/> 
  <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative</b> </p> <p> <b> status</b> : completed</p> <p> <b> medication</b> : <a>  </a> </p> <blockquote> <p> <b> code</b> : <span> Myleran 2mg tablet, film coated</span> </p> </blockquote> <p> <b> subject</b> : <a> Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald
           (OFFICIAL); gender: male</a> </p> <p> <b> effective</b> : 16 Jan. 2015, 8:03:00 am --&gt; 16 Jan. 2015, 12:03:00 pm</p> <h3> Performers</h3> <table> <tr> <td> -</td> <td> <b> Actor</b> </td> </tr> <tr> <td> *</td> <td> <a> Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone
               Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate:
               1971-11-07</a> </td> </tr> </table> <p> <b> request</b> : <a> Generated Summary: id: 12345689 (OFFICIAL); status: active; intent: order; Myleran 2mg
           tablet; authoredOn: 2015-01-15; <span> Chronic myeloid Leukemia (disorder)</span> </a> </p> <h3> Dosages</h3> <table> <tr> <td> -</td> <td> <b> Text</b> </td> <td> <b> Route</b> </td> <td> <b> Dose</b> </td> </tr> <tr> <td> *</td> <td> 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.
              With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL</td> <td> <span> Oral route (qualifier value)</span> </td> <td> 6 mg</td> </tr> </table> </div> </text> <contained> <Medication> 
      <id value="med0304"/> 
      <code> 
        <coding> 
          <system value="http://hl7.org/fhir/sid/ndc"/> 
          <code value="76388-713-25"/> 
          <display value="Myleran 2mg tablet, film coated"/> 
        </coding> 
      </code> 
  </Medication> 
  </contained> 
  <status value="completed"/> 
  <medicationReference> 
    <reference value="#med0304"/> 
  </medicationReference> 
 <subject> 
   <reference value="Patient/pat1"/> 
   <display value="Donald Duck"/>  
  </subject> 
 <effectivePeriod> 
  <start value="2015-01-15T22:03:00+01:00"/> 
   <end value="2015-01-16T02:03:00+01:00"/> 
</effectivePeriod> 
  <performer> 
    <actor> 
      <reference value="Practitioner/f007"/> 
      <display value="Patrick Pump"/> 
    </actor> 
  </performer> 
  <request> 
    <reference value="MedicationRequest/medrx0306"/> 
  </request> 
  <dosage> 
    <text value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count.
      With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL"/> 
    <route> 
      <coding> 
        <system value="http://snomed.info/sct"/> 
        <code value="26643006"/> 
        <display value="Oral route (qualifier value)"/> 
      </coding> 
    </route> 
    <dose> 
      <value value="6"/> 
      <unit value="mg"/> 
      <system value="http://unitsofmeasure.org"/> 
      <code value="mg"/> 
    </dose> 
  </dosage> 
</MedicationAdministration> 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.